Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Benard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Leukemia Research|March 5, 2019
Predicting response to new drugs in AML from simulation modelling: Value of the BEAT AML project as a validation resourceBrooks Benard, Daniel Thomas
Leukemia|February 8, 2019
Data mining for mutation-specific targets in acute myeloid leukemiaBrooks Benard, Andrew J Gentles, Thomas Köhnke, et al.
Science Translational Medicine|April 10, 2020
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemiaTian Yi Zhang, Ritika Dutta, Brooks Benard, et al.
Research Square|November 21, 2023
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Leukemia|March 12, 2024
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Leukemia Research|March 5, 2019
Predicting response to new drugs in AML from simulation modelling: Value of the BEAT AML project as a validation resourceBrooks Benard, Daniel Thomas
Leukemia|February 8, 2019
Data mining for mutation-specific targets in acute myeloid leukemiaBrooks Benard, Andrew J Gentles, Thomas Köhnke, et al.
Science Translational Medicine|April 10, 2020
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemiaTian Yi Zhang, Ritika Dutta, Brooks Benard, et al.
Research Square|November 21, 2023
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Leukemia|March 12, 2024
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 1